Hinge Health (HNGE) Research & Development (2024 - 2026)

Hinge Health has disclosed Research & Development across 3 years of filings, most recently posting $30.3 million for Q1 2026.

• Research & Development for Q1 2026 came in at $30.3 million, up 29.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $375.0 million (up 296.49% YoY), and the FY2025 annual result was $368.1 million, up 265.07% from the prior year.
• Research & Development came in at $30.3 million for Q1 2026 at Hinge Health, down from $32.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $280.0 million in Q2 2025 to a low of $22.4 million in Q4 2024.
• The 3-year median for Research & Development is $27.6 million (2024), against an average of $58.7 million.
• Across the five-year window, Research & Development jumped 1023.44% in 2025 and climbed 29.1% in 2026, its largest moves.
• Hinge Health's Research & Development stood at $22.4 million in 2024, then surged by 46.42% to $32.8 million in 2025, then fell by 7.38% to $30.3 million in 2026.
• The last three Research & Development figures came in at $30.3 million (Q1 2026), $32.8 million (Q4 2025), and $31.9 million (Q3 2025), per Business Quant data.